Patients with UC in remission also showed significantly higher levels of IL-6Rα compared to patients with active CC or LC, and gp130 compared to patients with active LC, LC-HR, and diarrhea controls. This evidence concerns the gene IL6R and laryngotracheoesophageal cleft.